D
Daniel Prieto-Alhambra
Researcher at University of Oxford
Publications - 438
Citations - 11189
Daniel Prieto-Alhambra is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 45, co-authored 345 publications receiving 7269 citations. Previous affiliations of Daniel Prieto-Alhambra include Erasmus University Medical Center & Mount Vernon Hospital.
Papers
More filters
Journal ArticleDOI
Validez del Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP) en el estudio de enfermedades vasculares: estudio EMMA
Rafel Ramos,Elisabet Balló,Jaume Marrugat,Roberto Elosua,Joan Sala,María Grau,Joan Vila,Bonaventura Bolíbar,Maria García-Gil,Ruth Martí,Francesc Fina,Eduardo Hermosilla,Magdalena Rosell,Miguel Ángel Muñoz,Daniel Prieto-Alhambra,Miquel Quesada +15 more
TL;DR: Las prevalencias de los factores de riesgo cardiovascular y su relacion with the incidencia de enfermedades vasculares observada en el EMMA concuerdan con las observadas en un estudio epidemiologico estandarizado de base poblacional.
Journal ArticleDOI
The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replacement or total knee replacement surgery
Gemma Wallace,Andrew Judge,Andrew Judge,Daniel Prieto-Alhambra,Daniel Prieto-Alhambra,Daniel Prieto-Alhambra,F. de Vries,F. de Vries,Nigel K Arden,Nigel K Arden,Cyrus Cooper,Cyrus Cooper +11 more
TL;DR: In this paper, the effect of obesity on 6-month post-operative complications following total knee (TKR) or hip (THR) replacement was assessed using logistic regression.
Journal ArticleDOI
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.
Jennifer C E Lane,James Weaver,Kristin Kostka,Talita Duarte-Salles,Maria Tereza Fernandes Abrahão,Heba Alghoul,Osaid Alser,Thamir M. Alshammari,Patricia Biedermann,Juan M. Banda,Edward Burn,Paula Casajust,Mitchell M. Conover,Aedín C. Culhane,Alexander Davydov,Scott L. DuVall,Scott L. DuVall,Dmitry Dymshyts,Sergio Fernandez-Bertolin,Kristina Fišter,Jill Hardin,Laura Hester,George Hripcsak,George Hripcsak,Benjamin Skov Kaas-Hansen,Seamus Kent,Sajan Khosla,Spyros Kolovos,Christophe G. Lambert,Johan van der Lei,Kristine E. Lynch,Kristine E. Lynch,Rupa Makadia,Andrea V. Margulis,Michael E. Matheny,Paras P. Mehta,Daniel R. Morales,H Morgan-Stewart,Mees Mosseveld,Danielle Newby,Fredrik Nyberg,Anna Ostropolets,Rae Woong Park,Albert Prats-Uribe,Gowtham A. Rao,Christian G. Reich,Jenna Reps,Peter R. Rijnbeek,Selva Muthu Kumaran Sathappan,Martijn J. Schuemie,Sarah Seager,Anthony G. Sena,Anthony G. Sena,Azza Shoaibi,Matthew E. Spotnitz,Marc A. Suchard,Carmine O. Torre,David Vizcaya,Haini Wen,Marcel de Wilde,Junqing Xie,Seng Chan You,Lin Zhang,Lin Zhang,Oleg Zhuk,Patrick B. Ryan,Patrick B. Ryan,Daniel Prieto-Alhambra +67 more
TL;DR: Hydxychloroquine treatment appears to have no increased risk in the short term among patients with rheumatoid arthritis, but in the long term it appears to be associated with excess cardiovascular mortality.
Journal ArticleDOI
Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
Daniel Prieto-Alhambra,Muhammad Javaid,Andrew Judge,David W. Murray,Andrew Carr,Cyrus Cooper,Nigel K Arden +6 more
TL;DR: In patients undergoing lower limb arthroplasty, bisphosphonate use was associated with an almost twofold increase in implant survival time and these findings require replication and testing in experimental studies for confirmation.
Journal ArticleDOI
Risks and Benefits of Bisphosphonate Therapies
TL;DR: The aims of this review are to compile the basic characteristics of bisphosphonates and outline the most important benefits and side effects and provide a clinical context as well as a research agenda to fill the gaps in knowledge.